# Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy

> **NCT02793687** · PHASE3 · COMPLETED · sponsor: **Pharmasoft** · enrollment: 150 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Mexidol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02793687
- **Lead sponsor:** Pharmasoft
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-06
- **Primary completion:** 2016-05-27
- **Final completion:** 2016-05-27
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02793687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02793687, "Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02793687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*